Poliovirus Surveillance: Building the Global Polio Laboratory Network
A network of virologic laboratories has been established by the World Health Organization to conduct surveillance for wild poliovirus and to provide evidence for the certification of poliomyelitis eradication. The network consists of >60 national laboratories isolating and identifying polioviruse...
Saved in:
Published in | The Journal of infectious diseases Vol. 175; no. Supplement-1; pp. S113 - S116 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
The University of Chicago Press
01.02.1997
University of Chicago Press Oxford University Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A network of virologic laboratories has been established by the World Health Organization to conduct surveillance for wild poliovirus and to provide evidence for the certification of poliomyelitis eradication. The network consists of >60 national laboratories isolating and identifying polioviruses within countries; 16 regional reference laboratories, providing intratypic differentiation of wild and vaccine strains and assisting with quality assurance and training; and 6 global specialized laboratories, conducting research, preparing reference reagents, and providing genomic sequencing of wild polioviruses, advanced training, and expert virologic advice. Laboratories collaborate with national eradication programs in the detection, reporting, clinical investigation, and virologic testing of stool specimens obtained in connection with cases of acute flaccid paralysis and, where indicated, from healthy children and the environment. A quality assurance system, leading to World Health Organization accreditation, involves training in standardized techniques, use of centrally prepared typing antisera, annual proficiency testing and follow-up action, and monitoring of standard performance indicators. |
---|---|
Bibliography: | ark:/67375/HXZ-BFS8D5L5-J Reprints or correspondence: Dr. Barbara Hull, Global Programme for Vaccines and Immunization, World Health Organization, CH-1211 Geneva 27, Switzerland. istex:EE4E7B7191D9E3CC9AB445B60A7DCF78334F2EC9 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0022-1899 1537-6613 |
DOI: | 10.1093/infdis/175.Supplement_1.S113 |